EntryPoint Capital LLC Acquires New Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

EntryPoint Capital LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 4,561 shares of the company’s stock, valued at approximately $357,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies during the 4th quarter worth $25,000. Continuum Advisory LLC increased its holdings in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares in the last quarter. Runnymede Capital Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $28,000. Bank of Jackson Hole Trust bought a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $32,000. Finally, Flagship Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $34,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $81.00 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a market cap of $37.04 billion, a PE ratio of 18.71, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The business’s 50 day moving average price is $86.86 and its two-hundred day moving average price is $85.93. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently commented on GEHC shares. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.